DAHUA-THERMAL-SOLUTION
2.3.2020 14:47:05 CET | Business Wire | Press release
The year 2020 is bound to be a special year with the outbreak of coronavirus disease 2019 (COVID-19) globally. Until today, the highly contagious disease has taken away many lives, especially in China, South Korea, Japan, and some countries in Europe and Middle East.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200302005479/en/
Dahua Technology, a world-leading video-centric smart IoT solution and service provider, has been an early participant in the epidemic prevention and control in Asia, joining the global efforts in combating the virus to minimize the impact on mankind. Since sending its first batch of thermal cameras to the hardest-hit area Wuhan on January 24th , Dahua thermal solution has been deployed in thousands of sites in China, including transportation hubs, commercial complexes, banks, and other places, and some are on the way to multiple countries in Asia.
Hong Kong, a financial capital in Asia, also suffers from the COVID-19 epidemic situation. Dahua Thermal Solution has been applied in some local business complexes, banks, company parks, and other places. To enable a safe and smooth work resumption recently, quite a few major corporations have been using Dahua Thermal Solution in their headquarters to improve their workplace safety, such as Paul Y. Engineering Group Limited. Dahua Thermal Solution measures the body temperature of their employees, handling thousands of staff flow every day. Compare to the traditional way of body temperature measurement – a forehead thermometer, using Dahua Thermal Solution will significantly improve speed and accuracy, meanwhile help reduce cross-infection via non-contact measurement. To measure the temperature of 5,000 people, it will take about 4.2 hours using a forehead thermometer, as it takes at least 3 seconds to measure a person. However, it takes only 30 minutes if you use Dahua Thermal Solution, which measures 3 person per second. It also features a high accuracy of ±0.3℃ .
“Dahua Thermal Solution helped us detect a couple of suspected cases in just a few hours of operation, which we greatly appreciate,” a Hongkong user commented.
Dahua Thermal Solution has been on the front line since the very beginning, helping with the epidemic prevention and control in airports, railway stations, hospitals, schools, and other sites all over Asia. Featuring high accuracy, high efficiency, strong adaptability and easy deployment, Dahua Thermal Solution can also be applied to all kinds of entrances and exits, kitchens and kindergartens.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200302005479/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press release
DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.6.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 74,700 shares. The options have an exercise price per share equal to $14.19, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restrict
Renewable Electricity, Soft Wheat Flour From Regenerative Agriculture, Initiatives to Support Local Communities: Barilla Shares These and Other Projects in “Stories of Sustainability.”5.6.2026 10:00:00 CEST | Press release
Barilla continues to advance its commitment to tastier products with less sugar and salt;An investment of 30 million euros in 2025 to quadruple photovoltaic capacity across plants, as part of a €168 million five-year plan focused on energy efficiency, renewable energy and sustainable water management.Barilla continues to expand regenerative agriculture practices across its global value chain, with over 816,000 tons of raw materials sourced through the Barilla Sustainable Farming program.4,000 tons of products donated worldwide and €2 million allocated to social causes in 2025, supporting communities across Barilla’s global footprint through food donations and social initiatives. A slimmer Tagliatelle pack that saves 150 tons of cardboard and cuts transport-related CO₂ emissions by 20%1; ready-made sauce jars made with around 65% recycled glass; the progressive scaling of regenerative agriculture practices across Barilla’s value chain and initiatives supporting inclusion and equal oppor
PUMA and Salehe Bembury Host Immersive Sound-Inspired Experience ahead of Football’s Biggest Tournament at The Row DTLA5.6.2026 09:59:00 CEST | Press release
Event Celebrated the launch of the PUMA x Salehe Bembury TRVL WEAR Collection and Velum 1 to be worn by PUMA’s 11 Federations this summer Global sports company PUMA and visionary designer Salehe Bembury hosted an immersive experience at The Row DTLA celebrating their collaboration ahead of football's biggest global tournament. The activation transformed the historic venue into a series of interactive environments, offering guests an inside look into the creative world behind the partnership. Set against the backdrop of Los Angeles, the event brought football beyond the pitch and into everyday life through the lens of sound and design. The PUMA x SALEHE BEMBURY collaboration kicks off PUMA’s second chapter of football introductions this summer, following the launch of their 11 national federation kits in March. This more streetwear-oriented launch introduces a bespoke collection of travel wear and goalkeeper kits for PUMA’s 11 national federations in the tournament. This press release f
Azafaros Announces Publication of Phase 2 RAINBOW Study Data for Nizubaglustat in Molecular Genetics and Metabolism Journal5.6.2026 07:00:00 CEST | Press release
Phase 2 RAINBOW study data showed that treatment with nizubaglustat in patients with GM2 gangliosidosis (GM2) and Niemann-Pick type C disease (NPC) reduced disease progression and seizure burdenTopline results from the study announced in 2024 demonstrated that nizubaglustat was safe and well tolerated, with encouraging signs of efficacyThe published data further supports the two ongoing registrational Phase 3 studies with nizubaglustat in GM1/GM2 and NPC Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced the publication of clinical data from its Phase 2 (RAINBOW) study in the peer reviewed journal, Molecular Genetics & Metabolism. The published manuscript reports efficacy, safety, pharmacokinetic and pharmacodynamic data which evaluated nizubaglustat in patients with genetically confirmed GM2 gangliosidosis and NPC. As previously stated in the topline results announcemen
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
